Retractable Technologies Research and Development Expenses 2010-2024 | RVP

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Retractable Technologies research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Retractable Technologies Research and Development Expenses 2010-2024 | RVP

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Retractable Technologies research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
McKesson (MCK)	$79.1B
Becton Dickinson (BDX)	$64.7B
Cardinal Health (CAH)	$29.5B
West Pharmaceutical Services (WST)	$22.9B
Cooper (COO)	$20.1B
Labcorp (LH)	$20B
Align Technology (ALGN)	$16.9B
Henry Schein (HSIC)	$9.4B
Merit Medical Systems (MMSI)	$6.1B
DENTSPLY SIRONA (XRAY)	$3.7B
CONMED (CNMD)	$2.3B
Patterson (PDCO)	$1.8B
STAAR Surgical (STAA)	$1.3B
Lifevantage (LFVN)	$178M
Pro-Dex (PDEX)	$152M